Skip to main content
S&P 5007,640.88+1.18%DOW51,785.18+0.63%NASDAQ26,427.27+1.73%BTC$76,508.00+1.00%ETH$2,448.74+2.09%GOLD$4,382.40-0.12%OIL$101.20-1.20%
Smart Investors Daily
AP

NASDAQ · APYX

Apyx Medical Corporation

Healthcare · Medical - Devices

$3.01

Down-$0.00 (-0.05%)

Updated Sep 17, 2026, 7:41 PM

SID Score

3.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
134.17M
P/E ratio
-9.16
Dividend yield
0.00%
52-week range
$2.76 – $5.08
Volume
80.99K
Avg. volume
107.62K

Price performance

APYX price history

1M range · 20 trading sessions · Daily adjusted prices

APYX closed at $3.01 after 20 trading sessions, down 4.44% for the selected period.

Last close
$3.01
Period change
-4.44%
Period low
$2.89
Period high
$3.15
Daily close
View OHLC price history
APYX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 16, 2026$2.97$3.075$2.90$3.0180.99K
Sep 15, 2026$3.03$3.03$2.90$2.9644.08K
Sep 14, 2026$2.88$3.03$2.875$3.0289.12K
Sep 11, 2026$2.90$3.07$2.79$2.90161.33K
Sep 10, 2026$3.05$3.07$2.87$2.8990.94K
Sep 9, 2026$3.05$3.055$3.00$3.0570.42K
Sep 8, 2026$2.97$3.07$2.97$3.05128.47K
Sep 4, 2026$3.06$3.08$3.02$3.0562.06K
Sep 3, 2026$3.08$3.08$2.96$3.06144.02K
Sep 2, 2026$3.07$3.11$3.05$3.0825.96K
Sep 1, 2026$3.07$3.11$3.01$3.05100.37K
Aug 31, 2026$3.05$3.1891$3.02$3.0546.73K
Aug 28, 2026$3.01$3.22$3.00$3.08115.65K
Aug 27, 2026$3.05$3.05$2.825$3.00815.87K
Aug 26, 2026$3.12$3.12$2.99$3.05116.67K
Aug 25, 2026$3.12$3.24$3.09$3.1148.43K
Aug 24, 2026$3.13$3.19$2.98$3.08119.57K
Aug 21, 2026$3.05$3.1704$3.04$3.1252.89K
Aug 20, 2026$3.15$3.29$3.03$3.0388.79K
Aug 19, 2026$3.17$3.26$3.09$3.15149.71K

Latest APYX news

The latest Smart Investors Daily articles mentioning APYX.

Stock researchCompany · Overview

APYX research

Overview

Company profile and research snapshot.

Company profile

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$8.50
Implied upside
—
Analysts
—
APYX recent ratings
DateFirmRatingTarget
Jul 13, 2026HC Wainwright & Co.Buy—
Mar 11, 2026Craig-HallumBuy—
Mar 11, 2026BTIGBuy—
Dec 16, 2025Roth CapitalBuy—
Nov 12, 2025CitizensMarket Outperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 15, 2026

Cold Plasma Market Forecasts Growth from $167.8M (2025) to $495.9M by 2033, Profiling Apyx Medical, Neoplas Med, Adtec Healthcare & 5 Other Key Players

Cold plasma adoption is rising in healthcare for sterilization, wound healing and cancer care, with opportunities in infection control, food safety, textiles and eco-friendly processing.Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Cold Plasma Market Size, Share & Trends Analysis Report by Pressure, Application, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. Global Cold Plasma Market to Reach USD 495.9 Million by 2033 as Healthcare Applications Expand

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By